Bauman JR, Liu G, Preeshagul I, Liu SV, et al. Corrigendum to "Real-world treatment sequencing and effectiveness of second- and third-generation ALK tyrosine kinase inhibitors for ALK-positive advanced non-small cell lung cancer" [Lung Cancer 195 (2024) 107919]. Lung Cancer 2025 Feb 22:108441. doi: 10.1016/j.lungcan.2025.108441.
PMID: 39988487